Macrogen Asia Pacific strives to enable everyone to lead happier and healthier lives by integrating knowledge of their genetics, healthcare, and lifestyle.
Next Generation Sequencing is the method of reading a genome by dividing it into many pieces, assembling the obtained sequence pieces and analyzing the sequence of the whole genome.
Capillary Electrophoresis Sequencing (CES) is a service that analyzes DNA sequences using a biochemical method.
Macrogen enables personalized diagnostics and treatments based on genetic tests such as for cancer genome, prenatal genome and rare disease genome.
Macrogen provides genomics services for research use, as well as clinical diagnostics worldwide, with laboratories in 6 countries, and more than 18,000 customers in 153 countries.
Research services include Next Generation Sequencing, Capillary Electrophoresis Sequencing, Microarrays, Transgenic mice, Oligonucleotide synthesis. Clinical services include hereditary cancer testing, somatic cancer panels, carrier testing, NIPT screening, clinical WGS and clinical WES.
The laboratories in Singapore, USA and Korea have received College of American Pathologists (CAP) accreditation. Our main laboratory in Korea also has certification by the Korean Institute of Genetic Testing Evaluation and NGS Clinical Laboratory Certification by the Korean Ministry of Food and Drug Safety.
Macrogen will be exhibiting at the 10x User Group Meeting at Biopolis on Oct 15, 2019. Hope to see you there!
Meet us at Hotel Fort Canning, 24-25 Sept, 2019, Singapore, at the Asia Skin Microbiome congress.
Exhibition booth showcases Macrogen services, including new CRISPR product launch.
Macrogen congratulates the Genome Institute of Singapore on their 20th anniversary, and leadership in genomics research.
Join us at the Precision Public Health Asia 2020 meeting. This event has been postponed to a later date due to the Covid-19 outbreak.